Home > Healthcare > Pharmaceuticals > Finished Drug Form > Compound Camphor Ointment Market

Compound Camphor Ointment Market Trends

Report ID: GMI9347
Published Date: May 2024
Report Format: PDF

Download Free Sample

Compound Camphor Ointment Market Trends

The increasing demand for natural remedies is a significant driver shaping its growth trajectory. Compound camphor ointments, derived from natural sources such as the camphor laurel tree, fit squarely into this preference for natural remedies. As consumers become more discerning about the ingredients in the products they use, the demand for camphor-based ointments is on the rise, driven by their perceived efficacy and holistic properties.
Concurrently, the rising prevalence of musculoskeletal disorders is driving the demand for compound camphor ointments. With an aging population and increasing sedentary lifestyles, musculoskeletal disorders such as arthritis, muscle strains, and joint pain are becoming more common worldwide.
Compound camphor ointments, known for their analgesic and anti-inflammatory properties, offer a non-invasive and accessible solution for managing musculoskeletal discomfort.
Thus, the growing incidence of these disorders coupled with increasing adoption of natural remedies is driving the overall growth of this market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The compound camphor ointment market was valued at USD 2.5 billion in 2023 and is anticipated to witness 4% CAGR during 2024-2032, owing to the rising prevalence of musculoskeletal disorders.

The retail pharmacies segment in the market will record 3.9% CAGR from 2024-2032, backed by the convenience and ease of access for customers seeking over the counter (OTC) remedies.

North America compound camphor ointment market size was valued at USD 1 billion in 2023 and is anticipated to reach USD 1.4 billion by the end of 2032, attributed to the significant investments in R&D.

Amrutanjan Health Care Limited, Caribe Natural LLC, Delon Laboratories Inc. DLC Laboratories Inc., Emu Joy, Focus Consumer Healthcare LLC, Greenbrier International, Inc., McKesson Canada, Thera Wise and World Perfumes Inc.